The Chan Zuckerberg Initiative and Innovative Genomics Institute launched the Center for Pediatric CRISPR Cures, backed by a $20 million grant. The Center aims to extend personalized CRISPR gene editing therapies, building from early successes like the treatment of a rare metabolic disease in an infant known as Baby KJ. It intends to develop therapies for multiple severe pediatric genetic diseases through refined CRISPR-based approaches, creating scalable models to accelerate access for families with ultra-rare conditions.